Advertisement

Pharma Companies Must be Allowed to Test Experimental Painkillers: FDA Panel

by Kathy Jones on  March 13, 2012 at 8:41 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Pharmaceutical companies should be allowed to continue testing experimental painkiller drugs for osteoarthritis according to a recommendation of an advisory panel for the US Food and Drug Administration.
 Pharma Companies Must be Allowed to Test Experimental Painkillers: FDA Panel
Pharma Companies Must be Allowed to Test Experimental Painkillers: FDA Panel

The panel recommended unanimously that the FDA should revoke its ban on companies such as Pfizer and Regeneron Pharmaceuticals and allow them to continue their clinical trials of the drugs.

The health regulator had suspended the testing on the drugs back in 2010 after finding that they destroyed the joints with nearly 500 participants in the clinical trials requiring joints replacements.

The recommendation was welcomed by the pharmaceutical companies with Pfizer senior vice president, Steve Romano saying, "Physicians and patients are in need of options for difficult-to-treat pain conditions and the panel's vote today is an important step towards helping us more fully understand the benefit-risk profile of this important new class of medicines."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Varicocele 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Advertisement

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive